Literature DB >> 1087319

Ontogeny of the antibody-forming cell line in mice. II. Maturation of B cells during fetal development.

Y J Rosenberg, A J Cunningham.   

Abstract

This paper maps the developmental stage reached by B cells in mouse fetuses of different ages. The "maturity" of these cells was assessed in a functional way by measuring the time taken for cells to generate antibody-forming progeny when injected into carrier-primed irradiated adult hosts and challenged daily with antigen. A steady uninterrupted progression in development of B cells occurred between 13 days of gestation and birth. There was no evidence for a stage during which B cells could only be paralyzed and not induced by antigen.

Entities:  

Mesh:

Year:  1976        PMID: 1087319

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Blocking of primary in vitro antibody responses to thymus-independent and thymus-dependent antigens with antiserum specific for IgM or IgD.

Authors:  J C Cambier; F S Ligler; J W Uhr; J R Kettman; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

2.  Clonal dominance: loss and restoration in adoptive transfer.

Authors:  D R Kaplan; J Quintans; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

3.  Maturation of bone marrow lymphocytes. II. Development of Fc and complement receptors and surface immunoglobulin studied by rosetting and radioautography.

Authors:  W C Yang; S C Miller; D G Osmond
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

4.  Immune response of neonates to pneumococcal polysaccharide-protein conjugate.

Authors:  K T Lin; C J Lee
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

5.  In vitro model for natural tolerance to self-antigens. Inhibition of the development of surface-immunoglobulin-negative lymphocytes into T-dependent responsive B cells by antigen.

Authors:  J M Teale; J E Layton; G J Nossal
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.